Hanover Insurance Group, Inc. (THG) shareholders
Close on Nov 16, 2026Market cap $8.63BP/E 12.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 3,291,658 | 9.20% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Portfolio Management | 1,939,338 | 5.51% | 13G (passive) | Mar 31, 2026 |
| T. Rowe Price Associates, Inc. | 1,831,584 | 5.20% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of THG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,532,932 | 10.28% | $756.47M | −148,234 | 0.01% |
| Vanguard Portfolio Management LLC | 1,919,628 | 5.58% | $411.03M | −12,832 | 0.02% |
| Price T Rowe Associates Inc /Md/ | 1,831,579 | 5.33% | $392.18M | +447,437 | 0.04% |
| State Street Corp | 1,627,020 | 4.73% | $348.38M | −4,402 | 0.01% |
| Vanguard Capital Management LLC | 1,458,761 | 4.24% | $312.35M | +6,406 | 0.01% |
| Aqr Capital Management LLC | 1,341,075 | 3.90% | $287.15M | +327,680 | 0.10% |
| Fuller & Thaler Asset Management, Inc. | 1,089,705 | 3.17% | $233.33M | +99,868 | 0.64% |
| American Century Companies Inc | 1,078,105 | 3.14% | $230.84M | +75,578 | 0.10% |
| Dimensional Fund Advisors LP | 1,030,544 | 3.00% | $220.66M | +60,367 | 0.04% |
| Alliancebernstein L.P. | 909,130 | 2.64% | $157.60M | +77,585 | 0.05% |
| First Trust Advisors LP | 824,257 | 2.40% | $176.49M | −3,063 | 0.10% |
| Geode Capital Management, LLC | 729,091 | 2.12% | $156.15M | +924 | 0.01% |
| Ameriprise Financial Inc | 699,163 | 2.03% | $149.71M | +4,392 | 0.03% |
| Massachusetts Financial Services Co /Ma/ | 595,647 | 1.73% | $127.54M | −3,139 | 0.04% |
| Charles Schwab Investment Management Inc | 453,309 | 1.32% | $97.06M | −17,521 | 0.01% |
| Invesco Ltd. | 452,418 | 1.32% | $96.87M | −466 | 0.01% |
| Morgan Stanley | 450,920 | 1.31% | $96.55M | −11,752 | 0.01% |
| Norges Bank | 447,262 | 1.30% | $95.77M | New | 0.01% |
| Vaughan Nelson Investment Management, L.P. | 372,514 | 1.08% | $79.76M | +207,804 | 0.71% |
| London Co Of Virginia | 360,801 | 1.05% | $77.26M | −20,867 | 0.44% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 546 | 32M | 93.2% | 84 / 208 | 168 / 39 | 3M | 3M |
| Q1 2026 | 507 | 31M | 91.2% | 67 / 197 | 156 / 48 | 7M | 5M |
| Q4 2025 | 496 | 33M | 95.5% | 76 / 180 | 159 / 35 | 4M | 3M |
| Q3 2025 | 460 | 31M | 91.5% | 66 / 175 | 142 / 35 | 2M | 3M |
| Q2 2025 | 433 | 32M | 94.0% | 48 / 169 | 154 / 49 | 2M | 2M |
| Q1 2025 | 437 | 32M | 93.9% | 78 / 155 | 128 / 40 | 3M | 2M |
| Q4 2024 | 405 | 32M | 92.3% | 64 / 151 | 122 / 28 | 2M | 2M |
| Q3 2024 | 377 | 32M | 93.0% | 50 / 154 | 118 / 38 | 6M | 2M |
| Q2 2024 | 369 | 32M | 91.8% | 51 / 132 | 129 / 26 | 2M | 3M |
| Q1 2024 | 347 | 32M | 93.9% | 45 / 120 | 117 / 39 | 2M | 1M |
| Q4 2023 | 343 | 32M | 91.8% | 45 / 124 | 118 / 33 | 3M | 3M |
| Q3 2023 | 334 | 31M | 91.2% | 36 / 124 | 125 / 36 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
478 funds held THG in Q2 2026, 46% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of THG | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 1,197,516 | 3.48% | $256.41M | 0.21% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 1,040,862 | 3.03% | $222.87M | 1.76% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 998,648 | 2.91% | $213.83M | 0.01% | Jun 30, 2026 |
| Avantis U.S. Small Cap Value ETF | 729,270 | 2.12% | $135.79M | 0.50% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 722,314 | 2.10% | $154.66M | 0.08% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 610,304 | 1.78% | $130.68M | 0.80% | Jun 30, 2026 |
| First Trust SMID Cap Rising Dividend Achievers ETF | 510,360 | 1.48% | $109.28M | 0.96% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 457,452 | 1.33% | $97.95M | 0.14% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 400,963 | 1.17% | $85.85M | 0.09% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Dividend ETF | 349,207 | 1.02% | $74.77M | 0.35% | Jun 30, 2026 |
| Columbia Select Mid Cap Value Fund | 291,697 | 0.85% | $54.31M | 1.79% | May 31, 2026 |
| MFS Mid Cap Value Fund | 276,506 | 0.80% | $59.21M | 0.34% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 233,200 | 0.68% | $49.93M | 0.34% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF | 220,891 | 0.64% | $51.39M | 0.94% | Jul 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 197,954 | 0.58% | $46.05M | 0.04% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| John C. Roche | President and CEO, Director | 165,678 | 0.48% | Nov 13, 2026 |
| Willard T. Lee | Executive Vice President | 6,004 | 0.02% | Nov 5, 2026 |
| Jeffrey M. Farber | Executive Vice President | 68,819 | 0.20% | Sep 28, 2026 |
| Richard W. Lavey | Executive Vice President | 34,475 | 0.10% | Sep 28, 2026 |
| David John Lovely | Executive Vice President | 3,829 | 0.01% | Sep 28, 2026 |
| Dennis Francis Kerrigan | Executive Vice President | 12,018 | 0.03% | Sep 28, 2026 |
| Patricia A. Norton-Gatto | SVP & Princpl. Accntg. Officer | 2,452 | 0.01% | Sep 28, 2026 |
| Bryan J. Salvatore | Executive Vice President | 29,118 | 0.08% | Sep 28, 2026 |
| Denise Lowsley | Executive Vice President | 8,058 | 0.02% | May 15, 2026 |
| Warren E. Barnes | SVP & Princpl. Accntg. Officer | 3,265 | 0.01% | Feb 26, 2025 |
| Theodore H. Bunting JR | Director | 5,388 | 0.02% | Nov 5, 2026 |
| Cynthia Egan | Director | 11,186 | 0.03% | Sep 28, 2026 |
| Francisco Aristeguieta | Director | 4,060 | 0.01% | Sep 28, 2026 |
| Kevin Bradicich | Director | 10,099 | 0.03% | Sep 28, 2026 |
| Jane D. Carlin | Director | 4,579 | 0.01% | Sep 28, 2026 |
| Elizabeth A. Ward | Director | 5,886 | 0.02% | Sep 28, 2026 |
| William E. Donnell | Director | 1,827 | 0.01% | Sep 28, 2026 |
| Kathy S. Lane | Director | 7,605 | 0.02% | Sep 28, 2026 |
| Joseph R. Ramrath | Director | 33,837 | 0.10% | Sep 28, 2026 |
| J. Paul Condrin | Director | 6,359 | 0.02% | Sep 28, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John C. Roche President and CEO, Director | Nov 12, 2026 | Sale | −2,929 | $250.00 | $732.24K | 151,224 |
| John C. Roche President and CEO, Director | Nov 12, 2026 | Sale | −10,393 | $249.37 | $2.59M | 154,153 |
| John C. Roche President and CEO, Director | Nov 12, 2026 | Sale | −1,100 | $247.93 | $272.73K | 164,546 |
| John C. Roche President and CEO, Director | Nov 11, 2026 | Tax withholding | −60,198 | $248.53 | $14.96M | 165,646 |
| John C. Roche President and CEO, Director | Nov 11, 2026 | Option exercise | +36,539 | $117.22 | $4.28M | 225,844 |
| John C. Roche President and CEO, Director | Nov 11, 2026 | Option exercise | +48,052 | $104.11 | $5.00M | 189,305 |
| Theodore H. Bunting JR Director | Nov 4, 2026 | Gift | −450 | – | – | 5,388 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Sale | −2,310 | $249.69 | $576.78K | 6,004 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Sale | −7,636 | $248.98 | $1.90M | 8,314 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Option exercise | +3,006 | $139.51 | $419.37K | 15,950 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Option exercise | +3,579 | $115.35 | $412.84K | 12,884 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Option exercise | +2,598 | $118.54 | $307.97K | 9,305 |
| Willard T. Lee Executive Vice President | Nov 4, 2026 | Option exercise | +703 | $117.22 | $82.41K | 6,707 |
| Kathy S. Lane Director | Sep 25, 2026 | Award | +3.7 | – | – | 2,776 |
| William E. Donnell Director | Sep 25, 2026 | Award | +3.7 | – | – | 850 |
| Elizabeth A. Ward Director | Sep 25, 2026 | Award | +3.7 | – | – | 5,886 |
| Jane D. Carlin Director | Sep 25, 2026 | Award | +3.7 | – | – | 2,273 |
| Kevin Bradicich Director | Sep 25, 2026 | Award | +3.7 | – | – | 10,099 |
| Francisco Aristeguieta Director | Sep 25, 2026 | Award | +3.7 | – | – | 4,060 |
| Cynthia Egan Director | Sep 25, 2026 | Award | +3.7 | – | – | 10,209 |
| Jeffrey M. Farber Executive Vice President | Sep 25, 2026 | Award | +41.9 | – | – | 68,819 |
| J. Paul Condrin Director | Sep 25, 2026 | Award | +3.7 | – | – | 6,359 |
| Willard T. Lee Executive Vice President | Sep 25, 2026 | Award | +10.64 | – | – | 6,004 |
| John C. Roche President and CEO, Director | Sep 25, 2026 | Award | +120.05 | – | – | 141,253 |
| Patricia A. Norton-Gatto SVP & Princpl. Accntg. Officer | Sep 25, 2026 | Award | +5.66 | – | – | 2,452 |
| Theodore H. Bunting JR Director | Sep 25, 2026 | Award | +3.7 | – | – | 5,838 |
| Dennis Francis Kerrigan Executive Vice President | Sep 25, 2026 | Award | +14.95 | – | – | 12,018 |
| David John Lovely Executive Vice President | Sep 25, 2026 | Award | +10.42 | – | – | 3,829 |
| Richard W. Lavey Executive Vice President | Sep 25, 2026 | Award | +27.91 | – | – | 34,475 |
| Joseph R. Ramrath Director | Sep 25, 2026 | Award | +3.7 | – | – | 33,837 |
| Bryan J. Salvatore Executive Vice President | Sep 25, 2026 | Award | +24.14 | – | – | 29,118 |
| Dennis Francis Kerrigan Executive Vice President | Aug 20, 2026 | Sale(10b5-1 plan) | −400 | $220.01 | $88.00K | 13,707 |
| Dennis Francis Kerrigan Executive Vice President | Aug 20, 2026 | Option exercise | +2,104 | $118.54 | $249.41K | 14,107 |
| Dennis Francis Kerrigan Executive Vice President | Aug 20, 2026 | Sale(10b5-1 plan) | −1,704 | $222.97 | $379.94K | 12,003 |
| Dennis Francis Kerrigan Executive Vice President | Aug 19, 2026 | Sale(10b5-1 plan) | −4,822 | $220.41 | $1.06M | 13,732 |
| Dennis Francis Kerrigan Executive Vice President | Aug 19, 2026 | Sale(10b5-1 plan) | −224 | $222.77 | $49.90K | 12,003 |
| Dennis Francis Kerrigan Executive Vice President | Aug 19, 2026 | Option exercise | +6,551 | $118.54 | $776.56K | 18,554 |
| Dennis Francis Kerrigan Executive Vice President | Aug 19, 2026 | Sale(10b5-1 plan) | −1,505 | $221.73 | $333.70K | 12,227 |
| Theodore H. Bunting JR Director | Aug 6, 2026 | Sale | −600 | $230.20 | $138.12K | 5,835 |
| Theodore H. Bunting JR Director | Aug 5, 2026 | Sale | −600 | $228.03 | $136.82K | 6,435 |
| Jane D. Carlin Director | Aug 3, 2026 | Sale | −1,000 | $231.50 | $231.50K | 2,270 |
| Jeffrey M. Farber Executive Vice President | Jul 29, 2026 | Option exercise | +26,832 | $118.54 | $3.18M | 99,023 |
| Jeffrey M. Farber Executive Vice President | Jul 29, 2026 | Option exercise | +19,084 | $115.35 | $2.20M | 118,107 |
| Jeffrey M. Farber Executive Vice President | Jul 29, 2026 | Tax withholding | −49,330 | $232.34 | $11.46M | 68,777 |
| Jeffrey M. Farber Executive Vice President | Jul 29, 2026 | Option exercise | +20,379 | $117.22 | $2.39M | 72,191 |
| Willard T. Lee Executive Vice President | Jun 26, 2026 | Award | +10.83 | – | – | 5,993 |
| Patricia A. Norton-Gatto SVP & Princpl. Accntg. Officer | Jun 26, 2026 | Award | +5.76 | – | – | 2,446 |
| Joseph R. Ramrath Director | Jun 26, 2026 | Award | +3.77 | – | – | 33,834 |
| Elizabeth A. Ward Director | Jun 26, 2026 | Award | +3.77 | – | – | 5,883 |
| J. Paul Condrin Director | Jun 26, 2026 | Award | +3.77 | – | – | 6,356 |
| Jane D. Carlin Director | Jun 26, 2026 | Award | +3.77 | – | – | 3,270 |
| Kathy S. Lane Director | Jun 26, 2026 | Award | +3.77 | – | – | 2,773 |
| Kevin Bradicich Director | Jun 26, 2026 | Award | +3.77 | – | – | 10,096 |
| Theodore H. Bunting JR Director | Jun 26, 2026 | Award | +3.77 | – | – | 7,035 |
| Francisco Aristeguieta Director | Jun 26, 2026 | Award | +3.77 | – | – | 4,057 |
| John C. Roche President and CEO, Director | Jun 26, 2026 | Award | +122.23 | – | – | 141,133 |
| Dennis Francis Kerrigan Executive Vice President | Jun 26, 2026 | Award | +15.22 | – | – | 12,003 |
| William E. Donnell Director | Jun 26, 2026 | Award | +3.77 | – | – | 847 |
| Jeffrey M. Farber Executive Vice President | Jun 26, 2026 | Award | +42.66 | – | – | 51,812 |
| Richard W. Lavey Executive Vice President | Jun 26, 2026 | Award | +28.42 | – | – | 34,447 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Hanover Insurance's stock actually held short. Settlement fails (shares not delivered on time) peaked at 419 shares on Sep 15, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Willard T. Lee Officer | Nov 4, 2026 | 9,946 | $2.48M | Nov 4, 2026 | Stock Option Exercise |
| Denise Lowsley Officer | Sep 16, 2026 | 9,864 | $2.28M | Sep 16, 2026 | Stock Option Exercise |
| Dennis Francis Kerrigan Officer | Aug 20, 2026 | 2,104 | $467.95K | Aug 20, 2026 | Stock Option Exercise |
| Dennis Francis Kerrigan Officer | Aug 19, 2026 | 6,551 | $1.45M | Aug 19, 2026 | Stock Option Exercise |
| Theodore H. Bunting JR Director | Aug 10, 2026 | 1,200 | $274.90K | Aug 4, 2026 | Restricted Stock |
| Jane D. Carlin Officer | Aug 3, 2026 | 1,000 | $231.50K | Aug 3, 2026 | Restricted Stock Vesting Under a Registered Plan |
| Bryan J. Salvatore Officer | Jun 3, 2026 | 16,394 | $3.05M | Jun 3, 2026 | Option Granted - 02/27/2018 |
| Francisco Aristeguieta Director | May 21, 2026 | 1,000 | $195.37K | May 21, 2026 | Compensation |
| John C. Roche Officer, Director | May 20, 2026 | 8,358 | $1.63M | May 20, 2026 | Stock Option Exercise |
| Dennis Francis Kerrigan Officer | May 20, 2026 | 6,262 | $1.21M | May 20, 2026 | Option Granted - 02/26/2021 |
| John C. Roche Officer, Director | May 18, 2026 | 5,251 | $1.03M | May 18, 2026 | Stock Option Exercise |
| Denise Lowsley Officer | May 14, 2026 | 4,175 | $800.47K | May 14, 2026 | Option Granted 02/26/2021 |
| Denise Lowsley Officer | May 8, 2026 | 1,062 | $200.11K | May 8, 2026 | ESPP Purchase |
| Willard T. Lee Officer | May 4, 2026 | 1,000 | $183.93K | May 4, 2026 | Restricted Stock Vesting |
| Cynthia Egan Director | May 1, 2026 | 3,400 | $640.90K | May 1, 2026 | Restricted Stock Vesting |
Congress trades
5 trades in Hanover Insurance reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Jefferson Shreve IN06 | Sold | May 12, 2025 | $15K–50K | Jun 22, 2025 |
| Thomas MacArthur NJ03 · joint account | Sold | Feb 1, 2016 | $15K–50K | Mar 3, 2016 |
| Thomas MacArthur NJ03 · joint account | Sold | Nov 10, 2015 | $1K–15K | Dec 6, 2015 |
| Thomas MacArthur NJ03 · joint account | Sold | Sep 24, 2015 | $1K–15K | Oct 8, 2015 |
| Thomas MacArthur NJ03 · joint account | Sold | May 4, 2015 | $1K–15K | Jun 7, 2015 |
See a number that looks wrong?